---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-027565"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:58:24.812099+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TransCode announces $10M registered direct offering of 10.25M shares and warrants at $0.98/unit

## Summary
- Gross proceeds of ~$10M from sale of 10.25M shares and 10.25M warrants at $0.98/unit.
- Warrants exercisable at $0.86/share, immediately exercisable, 5-year term.
- Placement agent receives warrants for 512,500 shares at $1.07/share.
- Net proceeds to fund clinical trials for lead candidate TTX-MC138 and working capital.
- Offering expected to close March 25, 2025.

## SEC filing metadata
- accession: 0001104659-25-027565
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925027565/0001104659-25-027565-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925027565/tm2510166d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-027565
- JSON: https://secwatch.observer/filing/0001104659-25-027565.json
- Plain text: https://secwatch.observer/filing/0001104659-25-027565.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.